11,249
Participants
Start Date
September 30, 2009
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
Non-steroidal anti-inflammatory drug (NSAID)
Participants who self-report that they have treated headaches with any drug in the non-steroidal anti-inflammatory drug (NSAID) class
Triptan
Participants who self-report that they have treated headaches with any drug in the NSAID class and any drug in the triptan class including naratriptan, sumatriptan, rizatriptan, frovatriptan, almotriptan, eletriptan, and zolmitriptan
Lead Sponsor
GlaxoSmithKline
INDUSTRY